Wes Hoffmann
wesjhoffmann.bsky.social
Wes Hoffmann
@wesjhoffmann.bsky.social
ID PharmD at Houston Methodist TMC. Interested in AMS and immunocompromised ID. Interests outside of ID include my kiddo, college basketball (Purdue specifically), and nature/animals!
I suppose it’s somewhat dependent. Most of the patients I see with urine source GNR bacteremia are older and frequently have some component of CKD, in which case 1g TID is my go to simply to make it easier for them. If it was a young patient, excellent clearance, would lean toward QID.
December 30, 2024 at 11:58 PM
Glad my memory was serving me correctly there! I don’t suppose there is a good publication on this that I can have stored away for future?
November 12, 2024 at 8:24 PM
Midlines were used regularly and preferentially for less than 2 week durations. If I recall correctly though at a prior institution, the vascular access team would avoid with vanc OPAT (even <2 weeks) as they felt the vanc caused more vascular problems in midlines (need to find the data).
November 12, 2024 at 12:50 AM